GigaMune Company
GigaMune focus on T cell therapeutics for solid tumors.
Technology:
Cell-based gene therapy
Industry:
Private
Headquarters:
South San Francisco, California, United States
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
300000
Last Funding Date:
2023-03-10
Last Funding Type:
Seed
Register and Claim Ownership